Georg Schett
Researcher Next ID · RN-023472
Researcher · Medicine
Karolinska University Hospital
Stockholm, Germany
- Works count
- 1,702
- Citation count
- 101,697
- H-index
- 156
- i10-index
- 885
Research interests
Publications
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2308917
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-02017-5
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
New England Journal of Medicine · 2021 · 10.1056/nejmc2107725
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Annals of the Rheumatic Diseases · 2020 · https://doi.org/10.1136/annrheumdis-2020-217159
EULAR definition of difficult-to-treat rheumatoid arthritis
Annals of the Rheumatic Diseases · 2020 · 10.1136/annrheumdis-2020-217344
Locally renewing resident synovial macrophages provide a protective barrier for the joint
Nature · 2019 · 10.1038/s41586-019-1471-1
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Nature Reviews Rheumatology · 2018 · 10.1038/s41584-018-0109-2
Enthesitis: from pathophysiology to treatment
Nature Reviews Rheumatology · 2017 · 10.1038/nrrheum.2017.188
Trial of Tocilizumab in Giant-Cell Arteritis
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1613849
Pathogenetic insights from the treatment of rheumatoid arthritis
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31472-1
Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss
Nature Communications · 2017 · 10.1038/s41467-017-02490-4
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
Cell Death and Differentiation · 2016 · 10.1038/cdd.2016.11
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-208337
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice
Annals of the Rheumatic Diseases · 2015 · 10.1136/annrheumdis-2014-206971
Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines
Nature Medicine · 2014 · 10.1038/nm.3547
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Nature Communications · 2012 · 10.1038/ncomms1734
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Nature Reviews Rheumatology · 2012 · 10.1038/nrrheum.2012.153
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Journal of Clinical Investigation · 2012 · 10.1172/jci60975
The Pathogenesis of Rheumatoid Arthritis
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmra1004965
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Nature · 2010 · 10.1038/nature09387
Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
The Journal of Experimental Medicine · 2008 · 10.1084/jem.20081165
Cytokines in the pathogenesis of rheumatoid arthritis
Nature reviews. Immunology · 2007 · https://doi.org/10.1038/nri2094
Dickkopf-1 is a master regulator of joint remodeling
Nature Medicine · 2007 · 10.1038/nm1538
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Circulation · 2004 · 10.1161/01.cir.0000127957.43874.bb
Osteoclasts are essential for TNF-α–mediated joint destruction
Journal of Clinical Investigation · 2002 · 10.1172/jci15582
Current projects
No projects listed.